Clinical Trial: Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07845552) titled 'Oral Food Challenge After One to Two Doses of Omalizumab Treatment for Food Allergy' on Sept. 22.

Brief Summary: The goal of this clinical trial is to learn how quickly omalizumab begins to work in people with food allergy. The main question it aims to answer is:

* Does omalizumab begin to work as early as 2 to 4 weeks after after starting treatment in people with food allergy?

Researchers will compare each participant's food challenge results at baseline before starting omalizumab, 2 to 4 weeks after starting omalizumab, and 4 to 6 months after starting omalizumab treatment.

Participants will:

* Have a baseline food challenge ...